The DOI matches its Crossref record; 418 of the 418 references it cites were found in a registry or an index.
Drug allergy: A 2022 practice parameter update
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 418
Management of Hypersensitivity Reactions to Taxanes
Picard, M. (2017) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2017.07.004 · Cited by 100
Caballero, M. L., Krantz, M. S., Quirce, S., Phillips, E. J., & Stone, C. A. (2021) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2021.03.002 · Cited by 100
Self-citationMori, F., Cianferoni, A., Barni, S., Pucci, N., Rossi, M. E., & Novembre, E. M. (2015) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2014.11.001 · Cited by 99
Evaluating Penicillin Allergies Without Skin Testing
Banks, T. A., Tucker, M. H., & Macy, E. M. (2019) · Current Allergy and Asthma Reports · doi:10.1007/s11882-019-0854-6 · Cited by 97
Sastre, J., Quijano, L.-D., Novalbos, A., Hernandez, G., Cuesta, J., Heras, M. D. L., Lluch, M., & Fernandez, M. (1996) · Allergy · doi:10.1111/j.1398-9995.1996.tb04634.x · Cited by 95
Biologic excipients: Importance of clinical awareness of inactive ingredients
Ionova, Y., & Wilson, L. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235076 · Cited by 95
Esmaeilzadeh, H., Nabavi, M., Aryan, Z., Arshi, S., Bemanian, M. H., Fallahpour, M., & Mortazavi, N. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.05.012 · Cited by 94
Hypersensitivity reactions to fluoroquinolones: analysis of the factors involved
Blanca‐López, N., Ariza, A., Doña, I., Mayorga, C., Montañez, M. I., Garcia‐Campos, J., Gómez, F., Rondón, C., Blanca, M., & Torres, M. J. (2013) · Clinical & Experimental Allergy · doi:10.1111/cea.12099 · Cited by 94
Blumenthal, K. G., Shenoy, E. S., Huang, M., Kuhlen, J. L., Ware, W., Parker, R. A., & Walensky, R. P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159406 · Cited by 94
Self-citationAllergy to monoclonal antibodies: cutting-edge desensitization methods for cutting-edge therapies
Hong, D. I., Bankova, L. G., Cahill, K. N., Kyin, T., & Castells, M. (2011) · Expert Review of Clinical Immunology · doi:10.1586/eci.11.75 · Cited by 93
Oral antibiotic adverse reactions after penicillin skin testing: multi‐year follow‐up
Macy, E. M., & Burchette, R. J. (2002) · Allergy · doi:10.1034/j.1398-9995.2002.23700.x · Cited by 93
Antibodies Predict Pegaspargase Allergic Reactions and Failure of Rechallenge
Liu, Y., Smith, C. A., Panetta, J. C., Yang, W., Thompson, L. E., Counts, J. P., Molinelli, A. R., Pei, D., Kornegay, N. M., Crews, K. R., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.02439 · Cited by 93
Junior, P. F. G.-B., Galvão, V. R., Picard, M., Caiado, J., & Castells, M. (2016) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2016.11.006 · Cited by 92
Gaeta, F., Valluzzi, R. L., Alonzi, C., Maggioletti, M., Caruso, C., & Romano, A. G. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.10.011 · Cited by 91
Identifying low-risk beta-lactam allergy patients in a UK tertiary centre.
Siew, L. Q. C., Li, P. H., Watts, T. J., Thomas, I., Ue, K. L., Caballero, M. R., Rutkowski, K., Till, S. J., Pillai, P., & Haque, R. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.03.015 · Cited by 89
Reactions to Rituximab in an Outpatient Infusion Center: A 5-Year Review
Levin, A. S., Otani, I. M., Lax, T. P., Hochberg, E. P., & Banerji, A. (2016) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2016.06.022 · Cited by 89
Self-citationPenicillin resensitization among hospitalized patients
Parker, P. J., PARRINELLO, J., Condemi, J. J., & ROSENFELD, S. I. (1991) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(91)90331-h · Cited by 88
Romano, A. G., Gaeta, F., Valluzzi, R. L., Maggioletti, M., Caruso, C., & Quaratino, D. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.01.025 · Cited by 88
Medication-Induced Interstitial Nephritis in the 21st Century
Nast, C. C. (2017) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2016.11.016 · Cited by 88
Female sex as a risk factor for penicillin allergy
Park, M. A., Matešić, D., Markus, P. J., & Li, J. T. C. (2007) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)60621-7 · Cited by 87
How to manage asparaginase hypersensitivity in acute lymphoblastic leukemia
Burke, M. J. (2014) · Future Oncology · doi:10.2217/fon.14.138 · Cited by 87
Diagnostic testing in suspected fluoroquinolone hypersensitivity
Seitz, C. S., Bröcker, E. ‐., & Trautmann, A. (2009) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2009.03338.x · Cited by 87
Hypersensitivity and immunologic reactions to biologics: opportunities for the allergist
Khan, D. A. (2016) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2016.05.013 · Cited by 87
Self-citationSulfonamide Hypersensitivity: Fact and Fiction
Khan, D. A., Knowles, S. R., & Shear, N. H. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.05.034 · Cited by 87
Self-citationCharacteristics of Meningitis Caused by Ibuprofen
Rodríguez, S. C., Olguín, A. M., Miralles, C. P., et al. (2006) · Medicine · doi:10.1097/01.md.0000229757.78057.50 · Cited by 86
Frequency of systematic reactions to penicillin skin tests
Valyasevi, M. A., & Dellen, R. G. V. (2000) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)62546-x · Cited by 86
Are Cephalosporins Safe for Use in Penicillin Allergy without Prior Allergy Evaluation?
Macy, E. M., & Blumenthal, K. G. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2017.07.033 · Cited by 86
Self-citationPenicillin Allergy Assessment in Pregnancy: Safety and Impact on Antibiotic Use
Wolfson, A. R., Mancini, C. M., Banerji, A., Fu, X., Bryant, A., Phadke, N. A., Shenoy, E. S., Arman, W., Zhang, Y., & Blumenthal, K. G. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.10.063 · Cited by 86
Self-citationBousquet, P., Co‐Minh, H. ‐., ARNOUX, B., Daurès, J., & Demoly, P. M. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.02.026 · Cited by 85
Severe adverse skin reactions to nonsteroidal antiinflammatory drugs: A review of the literature
Ward, K. E., Archambault, R., & Mersfelder, T. L. (2010) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp080603 · Cited by 85
Goodman, E. J., Morgan, M. J., Johnson, P. A., Nichols, B., Denk, N., & Gold, B. B. (2001) · Journal of Clinical Anesthesia · doi:10.1016/s0952-8180(01)00329-4 · Cited by 84
A protocol for risk stratification of patients with carboplatin-induced hypersensitivity reactions
Patil, S. U., Long, A. A., Ling, M. F., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.10.010 · Cited by 84
Castells, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01472 · Cited by 84
Labrosse, R., Paradis, L. P., Lacombe‐Barrios, J., Samaan, K., Graham, F. J., Paradis, J., Bégin, P., & Roches, A. D. (2018) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2018.01.030 · Cited by 84
Jerschow, E., Edin, M. L., Chi, Y., Hurst, B., Abuzeid, W. M., Akbar, N. A., Gibber, M. J., Fried, M. P., Han, W., Pelletier, T., et al. (2018) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2018.12.014 · Cited by 84
Larson, R. A., Fretzin, M., Dodge, R., & Schiffer, C. (1998) · Leukemia · doi:10.1038/sj.leu.2401007 · Cited by 83
* Immediate allergic reactions to amoxicillin
Vega, J. M., Blanca, M., Garcia, J. J., Carmona, M. J., Miranda, A., Perez-Estrada, M., Fernandez, S., Acebes, J. M., & Terrados, S. (1994) · Allergy · doi:10.1111/j.1398-9995.1994.tb02275.x · Cited by 82
Abacavir-Reactive Memory T Cells Are Present in Drug Naïve Individuals
Lucas, A., Lucas, M., Strhyn, A., Keane, N. M., McKinnon, E., Pavlos, R. K., Moran, E. M., Meyer-Pannwitt, V., Gaudieri, S., D'Orsogna, L. J. A., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117160 · Cited by 82
Self-citationRisk-stratified Management to Remove Low-Risk Penicillin Allergy Labels in the ICU
Stone, C. A., Stollings, J. L., Lindsell, C. J., Dear, M. L., Buie, R. B., Rice, T. W., & Phillips, E. J. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202001-0089le · Cited by 82
Self-citationAnaphylaxis associated with omalizumab administration: Risk factors and patient characteristics
Lieberman, P. L., Jones, I., Rajwanshi, R., Rosén, K. E., & Umetsu, D. T. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.07.013 · Cited by 81
Desai, S. H., Kaplan, M., Chen, Q., & Macy, E. M. (2017) · The Permanente Journal · doi:10.7812/tpp/16-080 · Cited by 79
Antibiotic-Induced Rash in Patients With Infectious Mononucleosis
Thompson, D. F., & Ramos, C. L. (2016) · Annals of Pharmacotherapy · doi:10.1177/1060028016669525 · Cited by 78
Aw, D. C., Tan, E. H., Chin, T. M., Lim, H. L., Lee, H. Y., & Soo, R. A. (2017) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.12687 · Cited by 78
Morales, D. R., Lipworth, B. J., Guthrie, B., Jackson, C., Donnan, P. T., & Santiago, V. H. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.10.057 · Cited by 77
Safety of cephalosporin administration to patients with histories of penicillin allergy
Daulat, S., Solensky, R., Earl, H. S., Casey, W., & Gruchalla, R. S. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.03.023 · Cited by 76
Self-citationRadiation Recall Dermatitis: Case Report and Review of the Literature
Hird, A. E., Wilson, J., Symons, S. P., Sinclair, E., Davis, M., & CHOW, E. (2008) · Current Oncology · doi:10.3747/co.2008.201 · Cited by 76
Rechallenge of immune checkpoint inhibitors: A systematic review and meta-analysis
Inno, A., Roviello, G., Ghidini, A., Luciani, A., Catalano, M., Gori, S., & Petrelli, F. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103434 · Cited by 76
Pharmacogenomics of off‐target adverse drug reactions
Garon, S. L., Pavlos, R. K., White, K. D., Brown, N. J., Stone, C. A., & Phillips, E. J. (2017) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13294 · Cited by 75
Self-citationJohannes, C. B., Ziyadeh, N. J., Seeger, J. D., Tucker, E., Reiter, C., & Faich, G. A. (2007) · Drug Safety · doi:10.2165/00002018-200730080-00007 · Cited by 74
Quiralte, J., Blanco, C., Delgado, J., et al. (2007) · PubMed · Cited by 74
Anaphylaxis after vaccination in a pediatric patient: further implicating alpha-gal allergy
Stone, C. A., Commins, S. P., Choudhary, S. K., Vethody, C., Heavrin, J. L., Wingerter, J., Hemler, J. A., Babe, K. S., Phillips, E. J., & Norton, A. E. (2018) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2018.06.005 · Cited by 74
Self-citationMoon, D. H., Lee, J.-M., Noonan, A. M., Annunziata, C. M., Minasian, L. M., Houston, N. D., Hays, J. L., & Kohn, E. C. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.389 · Cited by 73
Sachs, B., Riegel, S., Seebeck, J., Beier, R., Schichler, D., Barger, A., Merk, H. F., & Erdmann, S. (2006) · Drug Safety · doi:10.2165/00002018-200629110-00008 · Cited by 72
Detection of human IgE to sulfamethoxazole by skin testing with sulfamethoxazoyl-poly-l-tyrosine
Gruchalla, R. S., & Sullivan, T. J. (1991) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(91)90186-r · Cited by 72
Divekar, R. D., Hagan, J., Rank, M. A., Park, M., Volcheck, G. W., O’Brien, E. K., Meeusen, J. W., Kita, H., & Butterfield, J. H. (2016) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2016.03.004 · Cited by 72
Self-citationMacy, E. M., McCormick, T. A., Adams, J., Crawford, W., Nguyen, M. T., Hoang, L., Eng, V., Davis, A., & McGlynn, E. A. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.8367 · Cited by 72
Ramsey, A. C., & Staicu, M. L. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2017.11.012 · Cited by 71
Karnes, J. H., Miller, M. A., White, K. D., Konvinse, K. C., Pavlos, R. K., Redwood, A., Peter, J., Lehloenya, R. J., Mallal, S. A., & Phillips, E. J. (2018) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021818 · Cited by 71
Self-citationSolensky, R., Jacobs, J., Lester, M., Lieberman, P., McCafferty, F., Nilsson, T., Park, M., Schwarz, G., Soong, W., Wagelie-Steffen, A., et al. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.02.040 · Cited by 70
Association between penicillin allergy documentation and antibiotic use
Blumenthal, K. G., Kuper, K., Schulz, L. T., Bhowmick, T., Postelnick, M., Lee, F., & Walensky, R. P. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.2227 · Cited by 69
Self-citationTrubiano, J. A., Strautins, K., REDWOOD, A. J., Pavlos, R. K., Konvinse, K. C., Aung, A. K., Slavin, M. A., Thursky, K., Grayson, M. L., & Phillips, E. J. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2017.09.004 · Cited by 69
Self-citationPagani, M., Bavbek, S., Dursun, A. B., Bonadonna, P., Caralli, M. E., Cernadas, J., Cortellini, G., Costantino, M. T., Gelincik, A. A., Lucchini, G., et al. (2018) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2018.09.018 · Cited by 68
Drug Hypersensitivity Reactions Documented in Electronic Health Records within a Large Health System
Wong, A., Seger, D., Lai, K. H., Goss, F., Blumenthal, K., & Zhou, L. (2018) · Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2018.11.023 · Cited by 68
Self-citationOne-week Oral Challenge with Penicillin in Diagnosis of Penicillin Allergy
Hjortlund, J., Mortz, C. G., Skov, P. S., Eller, E., Poulsen, J., Borch, J. E., & Bindslev‐Jensen, C. (2012) · Acta Dermato Venereologica · doi:10.2340/00015555-1254 · Cited by 67
Pirmohamed, M., Aithal, G. P., Behr, E. R., Daly, A. K., & Roden, D. M. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.30 · Cited by 66
Aspirin Desensitization in Patients With Coronary Artery Disease
Rossini, R., Iorio, A., Pozzi, R., Bianco, M., Musumeci, G., Leonardi, S., Lettieri, C., Bossi, I. M., Colombo, P., Rigattieri, S., et al. (2017) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.116.004368 · Cited by 65
Outcomes from an inpatient beta-lactam allergy guideline across a large US health system
Blumenthal, K. G., Li, Y., Hsu, J. T., Wolfson, A. R., Berkowitz, D. N., Carballo, V. A., Schwartz, J. M., Marquis, K. A., Elshaboury, R. H., Gandhi, R. G., et al. (2019) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2019.50 · Cited by 65
Self-citationStevenson, B. R., Trevenen, M., Klinken, E., Smith, W., Yuson, C., Katelaris, C. H., Perram, F., Burton, P. K., Yun, J. J., Cai, F., et al. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.09.025 · Cited by 65
Mangan, B. L., McAlister, R. K., Balko, J. M., Johnson, D. B., Moslehi, J. J., Gibson, A., & Phillips, E. J. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14433 · Cited by 65
Self-citationYoon, S. ‐., Park, S. Y., Kim, S., Lee, T., Lee, Y. S., Kwon, H. ‐., Cho, Y. S., Moon, H., & Kim, T. (2013) · Allergy · doi:10.1111/all.12182 · Cited by 64
An economic analysis of aspirin desensitization in aspirin-exacerbated respiratory disease
Shaker, M. S., Lobb, A. L., Jenkins, P. C., O’Rourke, D. J., Takemoto, S. K., Sheth, S. D., Burroughs, T., & Dykewicz, M. S. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.06.047 · Cited by 64
Self-citationRisk-based pathway for outpatient penicillin allergy evaluations
Blumenthal, K. G., Huebner, E. M., Fu, X., Yu, L., Bhattacharya, G., Levin, A. S., Mancini, C. M., Slawski, B. R., & Banerji, A. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.04.006 · Cited by 64
Self-citationOral challenge with trimethoprim-sulfamethoxazole in patients with “sulfa” antibiotic allergy
Krantz, M. S., Stone, C. A., Abreo, A. M., & Phillips, E. J. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.07.003 · Cited by 64
Self-citationChu, D. K., Lee, D. J., Lee, K. M., Schünemann, H. J., Szczeklik, W., & Lee, J. M. (2019) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22428 · Cited by 64
Self-citationGenome-wide Study Identifies Association between HLA-B∗55:01 and Self-Reported Penicillin Allergy
Krebs, K., Bovijn, J., Zheng, N. S., Lepamets, M., Censin, J. C., Jürgenson, T., Särg, D., Abner, E., Laisk, T., Luo, Y., et al. (2020) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2020.08.008 · Cited by 62
Self-citationKeane, N. M., Pavlos, R. K., McKinnon, E., Lucas, A., Rive, C. M., Blyth, C. C., Dunn, D., Lucas, M., Mallal, S. A., & Phillips, E. J. (2014) · AIDS · doi:10.1097/qad.0000000000000345 · Cited by 61
Self-citationTolerance to aztreonam in patients allergic to betalactam antibiotics
Vega, J. M., Blanca, M., García, J. J., Miranda, A., Carmona, M. J., García, A., Moya, M., Sanchez, F., & Terrados, S. (1991) · Allergy · doi:10.1111/j.1398-9995.1991.tb00570.x · Cited by 61
Beta lactam allergy and resensitization in children with suspected beta lactam allergy
Hershkovich, J., Broides, A., Kirjner, L., Smith, H., & Gorodischer, R. (2009) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2008.03180.x · Cited by 60
Thong, B. Y., Mirakian, R. M., Castells, M., Pichler, W. J., Romano, A. G., Bonadonna, P., Deleanu, D. M., Kowalski, M. L., Yáñez, A., Lleonart, R., et al. (2011) · World Allergy Organization Journal · doi:10.1097/wox.0b013e31823dc02c · Cited by 59
Sánchez‐Borges, M., Caballero-Fonseca, F., & Capriles-Hulett, A. (2005) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)61205-7 · Cited by 59
A case of IgE-mediated hypersensitivity to ceftriaxone☆☆☆★
Romano, A. G., Quaratino, D., Venemalm, L., Torres, M. J., Venuti, A., & Blanca, M. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70100-4 · Cited by 59
Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: A case series
Picard, M., Drolet, J., Masse, M.-S., Filion, C. A., ALMuhizi, F., Fein, M. N., Copaescu, A. M., Isabwe, G. A. C., Blaquière, M., & Primeau, M.-N. (2021) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2021.11.021 · Cited by 59
Cheema, A. N., Mohammad, A., Hong, T., Jakubovic, H. R., Parmar, G., Sharieff, W., Garvey, M. B., Kutryk, M. J. B., Fam, N., Graham, J. J., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.040 · Cited by 58
Allergy to cefazolin: study of in vivo cross reactivity with other betalactams.
Igea, J. M., Fraj, J., Davila, I. J., Cuevas, M., Cuesta, J., & Hinojosa, M. (1992) · PubMed · Cited by 57
Fernández, T. D., Ariza, A., Palomares, F., Montañez, M. I., Salas, M. L., Ortiz, Á. M., Fernández‐Santamaría, R., Ruiz, A., Blanca, M., Mayorga, C., et al. (2016) · Medicine · doi:10.1097/md.0000000000003679 · Cited by 57
Nicoletti, P., Carr, D. F., Barrett, S., McEvoy, L., Friedmann, P. S., Shear, N. H., Nelson, M. R., Chiriac, A. M., Blanca‐López, N., Cornejo-García, J. A., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.10.004 · Cited by 57
Self-citationIammatteo, M., Blumenthal, K. G., Saff, R. R., Long, A. A., & Banerji, A. (2014) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2014.08.001 · Cited by 56
Self-citationPenicillin allergy label persists despite negative testing
Gerace, K. S., & Phillips, E. J. (2015) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2015.05.019 · Cited by 56
Self-citationPavlos, R. K., McKinnon, E., Ostrov, D. A., Peters, B., Buus, S., Koelle, D. M., Chopra, A., Schutte, R. J., Rive, C. M., Redwood, A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-08876-0 · Cited by 56
Self-citationMoss, R. B. (1991) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(91)90215-a · Cited by 55
Romano, A. G., Bousquet-Rouanet, L., Viola, M., Gaeta, F., Demoly, P. M., & Bousquet, P. (2009) · Allergy · doi:10.1111/j.1398-9995.2008.01874.x · Cited by 55
Bayer, G., Agier, M., Lioger, B., Lepelley, M., Zénut, M., Lanoue, M.-C., Maillot, F., & Jonville‐Béra, A. ‐. (2019) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2019.06.009 · Cited by 55
Park, M. A., Koch, C. A., Klemawesch, P., Joshi, A., & Li, J. T. (2010) · International Archives of Allergy and Immunology · doi:10.1159/000314367 · Cited by 54
Fox, S. J., & Park, M. A. (2014) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2014.04.013 · Cited by 53
Rituximab and Cytokine Release Syndrome
Kulkarni, H. S., & Kasi, P. M. (2012) · Case Reports in Oncology · doi:10.1159/000337577 · Cited by 53
Quiralte, J., Blanco, C., Castillo, R., Ortega, N., & Carrillo, T. (1997) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)63184-5 · Cited by 53
Che, D., Wang, J., Ding, Y., Liu, R., Cao, J., Zhang, Y., Hou, Y., An, H., Gao, Z., & Zhang, T. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.08.005 · Cited by 53
Self-citationLam, P. W., Tarighi, P., Elligsen, M., Gunaratne, K., Nathens, A. B., Tarshis, J., & Leis, J. A. (2020) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2019.374 · Cited by 53
Urticaria: The 1-1-1 Criterion for Optimized Risk Stratification in β-Lactam Allergy Delabeling
Sabato, V., Gaeta, F., Valluzzi, R. L., Gasse, A. L. V., Ebo, D. G., & Romano, A. G. (2021) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2021.05.037 · Cited by 53
Yang, M., Kang, D. Y., Seo, B., Park, H. J., Park, S. Y., Kim, M., Park, K. H., Koo, S., Nam, Y., Kim, S., et al. (2018) · Allergy · doi:10.1111/all.13435 · Cited by 52
Testing Strategies and Predictors for Evaluating Immediate and Delayed Reactions to Cephalosporins
Stone, C. A., Trubiano, J. A., & Phillips, E. J. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.07.056 · Cited by 52
Self-citationA review of drug patch testing and implications for HIV clinicians
Shear, N. H., Milpied, B., Bruynzeel, D. P., & Phillips, E. J. (2008) · AIDS · doi:10.1097/qad.0b013e3282f7cb60 · Cited by 51
Self-citationBooster responses in the study of allergic reactions to beta-lactam antibiotics.
Mc, L.-S., Caballero, T., Barranco, P., et al. (1997) · PubMed · Cited by 51
Clinical outcomes of penicillin skin testing
Nadarajah, K., Green, G. R., & Naglak, M. C. (2005) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)61016-2 · Cited by 50
Krantz, M. S., Liu, Y., Phillips, E. J., & Stone, C. A. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.12.041 · Cited by 50
Self-citationKeating, K. N., Walko, C. M., Stephenson, B., O’Neil, B. H., & Weiss, J. (2013) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155213510542 · Cited by 49
Balancing Cancer Immunotherapy Efficacy and Toxicity
Johnson, D. B., Jakubovic, B. D., Sibaud, V., & Sise, M. E. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.06.028 · Cited by 49
Penicillin Allergy: Value of Including Amoxicillin as a Determinant in Penicillin Skin Testing
Lin, E., Saxon, A., & Riedl, M. A. (2010) · International Archives of Allergy and Immunology · doi:10.1159/000288284 · Cited by 48
Højfeldt, S. G., Wolthers, B. O., Tulstrup, M., Abrahamsson, J., Gupta, R., Harila‐Saari, A. H., Heyman, M. M., Henriksen, L. T., Jónsson, Ó. G., Lähteenmäki, P. M., et al. (2018) · British Journal of Haematology · doi:10.1111/bjh.15660 · Cited by 48
Elective penicillin skin testing in a pediatric outpatient setting
Jost, B. C., Wedner, H. J., & Bloomberg, G. R. (2006) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)60973-8 · Cited by 47
Skin Testing in the Evaluation and Management of Carboplatin-Related Hypersensitivity Reactions
Lax, T. P., Long, A. A., & Banerji, A. (2015) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2015.07.003 · Cited by 47
Self-citationSteroid Allergy: Clinical Features and the Importance of Excipient Testing in a Diagnostic Algorithm
Li, P. H., Wagner, A., Θωμάς, Ι., Watts, T. J., Rutkowski, R., & Rutkowski, K. (2018) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2018.01.007 · Cited by 47
Banerji, A., Wolfson, A. R., Wickner, P. G., Cogan, A. S., McMahon, A. E., Saff, R. R., Robinson, L. B., Phillips, E. J., & Blumenthal, K. G. (2021) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2021.03.053 · Cited by 47
Self-citationFrigas, E., Park, M. A., Narr, B. J., Volcheck, G. W., Danielson, D. R., Markus, P. J., Olson, K. E. K., Schroeder, D. R., & Kita, H. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.6.651 · Cited by 46
Chang, B., Knowles, S. R., & Weber, E. (2010) · Annals of Pharmacotherapy · doi:10.1345/aph.1m579 · Cited by 46
The Importance of Prolonged Provocation in Drug Allergy — Results From a Danish Allergy Clinic
Fransson, S., Mosbech, H., Kappel, M., Hjortlund, J., Poulsen, L. K., Kvisselgaard, A. D., & Garvey, L. H. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2017.02.024 · Cited by 46
Lezmi, G., Alrowaishdi, F., Bados‐Albiero, A., Scheinmann, P., Jacques de, B. L. I. C., & Ponvert, C. (2017) · Pediatric Allergy and Immunology · doi:10.1111/pai.12826 · Cited by 46
Sánchez‐Borges, M., Caballero-Fonseca, F., & Capriles-Hulett, A. (2005) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)61282-3 · Cited by 45
Kutszegi, N., Yang, X., Gézsi, A., Schermann, G., Erdelyi, D. J., Semsei, Á. F., Gábor, K. M., Sági, J. C., Kovács, G., Falus, A., et al. (2017) · Haematologica · doi:10.3324/haematol.2017.168211 · Cited by 45
Pruritus Associated with Targeted Anticancer Therapies and Their Management
Wu, J., & Lacouture, M. E. (2018) · Dermatologic Clinics · doi:10.1016/j.det.2018.02.010 · Cited by 45
Drug‐induced aseptic meningitis: 329 cases from the French pharmacovigilance database analysis
Bihan, K., Weiss, N., Théophile, H., Funck‐Brentano, C., & Lebrun‐Vignes, B. (2019) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14073 · Cited by 45
Exius, R., Gabrielli, S., Abrams, E. M., O’Keefe, A., Protudjer, J. L. P., Lavine, E., Pitt, T. J., Atkinson, A. R., Eiwegger, T., McCusker, C. T., et al. (2021) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2021.06.057 · Cited by 45
Caiado, J., & Picard, M. (2014) · Current Allergy and Asthma Reports · doi:10.1007/s11882-014-0451-7 · Cited by 44
Saif, M. W., Peccerillo, J., & Potter, V. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0831-6 · Cited by 44
Wang, A., Patil, S., Long, A., & Banerji, A. (2015) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2015.07.017 · Cited by 44
Self-citationArıkoğlu, T., Aslan, G., Yıldırım, D. D., Batmaz, S. B., & Kuyucu, S. (2016) · Allergology International · doi:10.1016/j.alit.2016.10.004 · Cited by 44
Frequency of severe reactions following penicillin drug provocation tests: A Bayesian meta‐analysis
Cardoso‐Fernandes, A., Blumenthal, K. G., Chiriac, A. M., Tarrio, I., João, D., Delgado, L., Fonseca, J., Azevedo, L. F., & Sousa‐Pinto, B. (2021) · Clinical and Translational Allergy · doi:10.1002/clt2.12008 · Cited by 44
Self-citationPyle, R. C., Butterfield, J. H., Volcheck, G. W., Podjasek, J. C., Rank, M. A., Li, J. T. C., Harish, A., Poe, K. L., & Park, M. A. (2014) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2013.11.002 · Cited by 43
Self-citationA desensitization protocol for the mAb cetuximab
Jerath, M. R., Kwan, M., Kannarkat, M., Mirakhur, B., Carey, L., Valgus, J. M., Platts‐Mills, T. A. E., & Tarrant, T. K. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.09.046 · Cited by 43
Identifying Allergic Drug Reactions Through Placebo-Controlled Graded Challenges
Iammatteo, M., Ferastraoaru, D. E., Koransky, R., Arango, S. A., Thota, N., Akenroye, A. T., & Jerschow, E. (2016) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2016.09.041 · Cited by 43
Moxifloxacin hypersensitivity: Uselessness of skin testing
Uyttebroek, A. P., Sabato, V., Bridts, C. H., Clerck, L. S. D., & Ebo, D. G. (2015) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2014.12.012 · Cited by 42
Biomarkers for Immunotherapy Toxicity: Are Cytokines the Answer?
Johnson, D. B., & Balko, J. M. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3858 · Cited by 42
Seitz, C. S., Bröcker, E., & Trautmann, A. (2011) · Allergologia et Immunopathologia · doi:10.1016/j.aller.2010.06.008 · Cited by 41
Piperacillin-Tazobactam Hypersensitivity: A Large, Multicenter Analysis
Casimir-Brown, R. S., Kennard, L., Kayode, O. S., Siew, L. Q. C., Makris, M. P., Tsilochristou, O., Chytiroglou, E., Nakonechna, A., Rutkowski, K., Mirakian, R. M., et al. (2021) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.12.051 · Cited by 41
Jatoi, A., & Nguyen, P. (2008) · The Oncologist · doi:10.1634/theoncologist.2008-0149 · Cited by 40
Tolerability of Cefazolin and Ceftibuten in Patients with IgE-Mediated Aminopenicillin Allergy
Romano, A. G., Valluzzi, R. L., Caruso, C., Zaffiro, A., Quaratino, D., & Gaeta, F. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.02.025 · Cited by 40
Understanding Toxicities of Targeted Agents: Implications for Anti-tumor Activity and Management
Liu, S., & Kurzrock, R. (2015) · Seminars in Oncology · doi:10.1053/j.seminoncol.2015.09.032 · Cited by 39
Implementation of a penicillin allergy screening tool to optimize aztreonam use
Staicu, M. L., Brundige, M. L., Ramsey, A. C., Brown, J. E., Yamshchikov, A. V., Peterson, D. R., Baran, A. M., & Laguio-Vila, M. R. (2016) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp150288 · Cited by 39
Lee, J.-H., Moon, M., Kim, Y. C., Chung, S. J., Oh, J., Kang, D. Y., Lee, S., Lee, K.-H., Yun, J. J., & Kang, H. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.10.014 · Cited by 39
Colli, L. D., Gabrielli, S., Abrams, E. M., O’Keefe, A., Protudjer, J. L. P., Lavine, E., Pitt, T. J., Atkinson, A. R., Eiwegger, T., McCusker, C. T., et al. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.08.047 · Cited by 39
Impact of an extended challenge on the effectiveness of β-lactam hypersensitivity investigation
Ratzon, R., Reshef, A., Efrati, O., Deutch, M., Forschmidt, R., Cukierman‐Yaffe, T., Kenett, R. S., & Kidon, M. I. (2016) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2016.01.018 · Cited by 38
First-dose anaphylaxis to infliximab: a case of mammalian meat allergy
Chitnavis, M. V., Stein, D. J., Commins, S. P., Schuyler, A. J., & Behm, B. W. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2017.04.044 · Cited by 38
Pavlos, R. K., White, K. D., Wanjalla, C. N., Mallal, S. A., & Phillips, E. J. (2017) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2017.07.007 · Cited by 38
Self-citationPreoperative penicillin allergy testing in patients undergoing cardiac surgery
Plager, J. H., Mancini, C. M., Fu, X., Melnitchouk, S. I., Shenoy, E. S., Banerji, A., Collier, L., Chaudhary, N., Yerneni, S., Zhang, Y., et al. (2020) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2020.03.013 · Cited by 38
Self-citationSalmeterol Prevents Aspirin-induced Attacks of Asthma and Interferes with Eicosanoid Metabolism
Szczeklik, A., Dworski, R., Mastalerz, L., Prokop, A., Sheller, J. R., Niżankowska, E., Ćmiel, A., & Oates, J. A. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.4.9710043 · Cited by 37
Immediate hypersensitivity reactions to ibuprofen and other arylpropionic acid derivatives
Blanca‐López, N., Pérez‐Alzate, D., Andreu, I., Doña, I., Agúndez, J. A. G., García‐Martín, E., Salas, M. L., Miranda, M. A., Torres, M. J., Cornejo-García, J. A., et al. (2016) · Allergy · doi:10.1111/all.12855 · Cited by 37
Afatinib-associated Stevens-Johnson syndrome in an EGFR-mutated lung cancer patient
Doesch, J., Debus, D., Meyer, C. T., et al. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.02.015 · Cited by 37
Improving Aztreonam Stewardship and Cost Through a Penicillin Allergy Testing Clinical Guideline
Chen, J. R., Tarver, S. A., Alvarez, K., Wei, W., & Khan, D. A. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy106 · Cited by 37
Self-citationControversies in Allergy: Chemotherapy Reactions, Desensitize, or Delabel?
Hong, D. I., Madrigal‐Burgaleta, R., Banerji, A., Castells, M., & Álvarez-Cuesta, E. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.08.005 · Cited by 37
Self-citationCetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
Arnold, D., & Misbah, S. (2008) · New England Journal of Medicine · doi:10.1056/nejmc080834 · Cited by 36
Aspirin-exacerbated respiratory disease: not always “adult-onset”
Tuttle, K. L., Schneider, T. R., Henrickson, S. E., Morris, D., Abonia, J. P., Spergel, J. M., & Laidlaw, T. M. (2016) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2016.05.016 · Cited by 36
Gasse, A. L. V., Ebo, D. G., Chiriac, A. M., Hagendorens, M. M., Faber, M. A., Coenen, S., Bridts, C. H., Mertens, C. H., Clerck, L. S. D., & Sabato, V. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.04.021 · Cited by 36
Full-Course Drug Challenge Test in the Diagnosis of Delayed Allergic Reactions to Penicillin
Borch, J. E., & Bindslev‐Jensen, C. (2011) · International Archives of Allergy and Immunology · doi:10.1159/000320384 · Cited by 35
Omalizumab and hypersensitivity reactions
Shankar, T., & Petrov, A. A. (2012) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e32835bf3f5 · Cited by 35
The Safety and Interpretability of Skin Tests with Omalizumab
Lieberman, P. L., Rahmaoui, A., & Wong, D. A. (2010) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2010.10.008 · Cited by 34
Negative predictive value of drug provocation tests in children
Mısırlıoğlu, E. D., Toyran, M., Çapanoğlu, M., Kaya, A., Civelek, E., & Kocabaş, C. N. (2014) · Pediatric Allergy and Immunology · doi:10.1111/pai.12286 · Cited by 34
Safety of high-dose rofecoxib in patients with aspirin-exacerbated respiratory disease
Woessner, K. M., Simon, R. A., & Stevenson, D. D. (2004) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)61392-0 · Cited by 34
Lehloenya, R. J., Isaacs, T., Nyika, D. T., Dhana, A. V., Knight, L., Veenstra, S. H., & Peter, J. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.08.012 · Cited by 34
Selective type-1 hypersensitivity to cefuroxime
Romano, A. G., Quaratino, D., Venuti, A., Venemalm, L., Mayorga, C., & Blanca, M. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70368-9 · Cited by 33
Verma, A. R., Chen, K., Bender, C., Gorney, N., Leonard, W., & Barnette, P. (2019) · Pediatric Hematology and Oncology · doi:10.1080/08880018.2019.1634778 · Cited by 33
Galvão, V. R., Phillips, E., Junior, P. F. G.-B., & Castells, M. (2016) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2016.08.012 · Cited by 32
Self-citationApproach to patients with aspirin hypersensitivity and acute cardiovascular emergencies
White, A. A., Stevenson, D. D., Woessner, K. M., et al. (2013) · Allergy and Asthma Proceedings · doi:10.2500/aap.2013.34.3644 · Cited by 31
Self-citationHansen, N. L., Chandiramani, D. V., Morse, M. A., Wei, D., Hedrick, N. E., & Hansen, R. A. (2010) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155209360853 · Cited by 31
Li, L., Bensko, J. C., Buchheit, K. M., Saff, R. R., & Laidlaw, T. M. (2021) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2021.11.006 · Cited by 31
Steinke, J. W., Payne, S. C., & Borish, L. (2012) · Journal of Allergy · doi:10.1155/2012/182090 · Cited by 30
Successful Desensitization of Three Patients with Hypersensitivity Reactions to Omalizumab
Owens, G. R., & Petrov, A. A. (2011) · Current Drug Safety · doi:10.2174/157488611798918692 · Cited by 30
Risk of Hypersensitivity to Biologic Agents Among Medicare Patients With Rheumatoid Arthritis
Yun, H., Xie, F., Beyl, R. N., Chen, L., Lewis, J. D., Saag, K. G., & Curtis, J. R. (2016) · Arthritis Care & Research · doi:10.1002/acr.23141 · Cited by 30
Mawhirt, S. L., Fonacier, L. S., Calixte, R., Davis-Lorton, M. A., & Aquino, M. (2016) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2016.10.003 · Cited by 30
Drug Desensitizations for Chemotherapy: Safety and Efficacy in Preventing Anaphylaxis
Caiado, J., & Castells, M. (2021) · Current Allergy and Asthma Reports · doi:10.1007/s11882-021-01014-x · Cited by 30
Allouchery, M., Beuvon, C., Pérault‐Pochat, M., Roblot, P., Puyade, M., & Martin, M. (2022) · Cancers · doi:10.3390/cancers14040955 · Cited by 30
Adverse reactions during drug challenges: a single US institution's experience
Kao, L., Rajan, J. P., Roy, L., Kavosh, E. R., & Khan, D. A. (2012) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2012.11.007 · Cited by 29
Self-citationOverview and Insights into Carbapenem Allergy
Lee, Y., & Bradley, N. E. (2019) · Pharmacy · doi:10.3390/pharmacy7030110 · Cited by 29
Safety of cephalosporins in penicillin class severe delayed hypersensitivity reactions
Trubiano, J. A., Chua, K., Holmes, N. E., Douglas, A. P., Mouhtouris, E., Goh, M., & Phillips, E. J. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.10.005 · Cited by 29
Self-citationImmunotherapy-Induced Airway Disease: A New Pattern of Lung Toxicity of Immune Checkpoint Inhibitors
Mitropoulou, G., Daccord, C., Sauty, A., Pasche, A., Egger, B., Lopez, V. A., Letovanec, I., Beigelman‐Aubry, C., Nicod, L. P., & Lazor, R. (2020) · Respiration · doi:10.1159/000504968 · Cited by 29
Cetuximab hypersensitivity infusion reactions: Incidence and risk factors
Hopps, S., Medina, P. J., Pant, S., Webb, R. D., Moorman, M., & Borders, E. B. (2012) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155212462440 · Cited by 28
Pharmacogenomics and adverse drug reactions: Primetime and not ready for primetime tests
Khan, D. A. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.08.002 · Cited by 28
Self-citationDorman, S. M., Seth, S., & Khan, D. A. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2017.06.014 · Cited by 28
Self-citationBertram, C. M., Postelnick, M. J., Mancini, C. M., Fu, X., Zhang, Y., Schulz, L. T., Bhowmick, T., Lee, F., & Blumenthal, K. G. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1762 · Cited by 27
Self-citationAhmed, K. A., Fox, S. J., Frigas, E., & Park, M. A. (2012) · International Archives of Allergy and Immunology · doi:10.1159/000333553 · Cited by 26
Hermans, M. A. W., van der Vet, S. Q. A., van Hagen, P. M., van Wijk, R. G., & van Daele, P. L. A. (2018) · Allergy · doi:10.1111/all.13445 · Cited by 26
Preventing iatrogenic gelatin anaphylaxis
Jiang, Y., Yuan, I. H., Dutille, E. K., Bailey, R., & Shaker, M. S. (2019) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2019.07.017 · Cited by 26
Self-citationCephalosporin Hypersensitivity: Descriptive Analysis, Cross-Reactivity, and Risk Factors
Touati, N., Cardoso, B. K., Delpuech, M., Bazire, R., Kara, N. E., Ouali, D., Demoly, P. M., & Chiriac, A. M. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.11.063 · Cited by 26
Swearingen, S. M., White, C., Weidert, S., Hinds, M., Narro, J. P., & Guarascio, A. J. (2016) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-016-0248-y · Cited by 25
Immediate cephalosporin allergy
Yuson, C., Kumar, K., Le, A., Ahmadie, A., Banovic, T., Heddle, R. J., Kette, F. E., Smith, W., & Hissaria, P. (2019) · Internal Medicine Journal · doi:10.1111/imj.14229 · Cited by 25
Acute care beta-lactam allergy pathways: approaches and outcomes
Wolfson, A. R., Huebner, E. M., & Blumenthal, K. G. (2019) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2019.04.009 · Cited by 25
Self-citationSacco, K. A., Cochran, B. P., Epps, K. L., Parkulo, M. A., & Gonzalez‐Estrada, A. (2018) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2018.11.008 · Cited by 24
Krantz, M. S., Stone, C. A., Yu, R. J., Adams, S. N., & Phillips, E. J. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.09.017 · Cited by 24
Self-citationDeterminants of nocebo effect during oral drug provocation tests
Bavbek, S., Aydın, Ö., Sözener, Z. Ç., & Yüksel, S. (2014) · Allergologia et Immunopathologia · doi:10.1016/j.aller.2014.04.008 · Cited by 23
Matheu, V. M., Pérez, E., González, R., Poza, P., de la Torre, F., Sánchez‐Machín, I., & García-Robaina, J. C. (2007) · PubMed · Cited by 22
Estep, P. M., Ferreira, J., Dupree, L. H., Aldridge, P. J., & Jankowski, C. A. (2016) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp150440 · Cited by 22
Evaluating Immediate Reactions to Cephalosporins: Time Is of the Essence
Romano, A. G., Valluzzi, R. L., Caruso, C., Zaffiro, A., Quaratino, D., & Gaeta, F. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.11.032 · Cited by 22
Utility of minor determinants for skin testing in inpatient penicillin allergy evaluation
Geng, B., Eastman, J. J., Mori, K. H., Braskett, M., & Riedl, M. A. (2017) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2017.06.009 · Cited by 21
Flucloxacillin Hypersensitivity: Patient Outcomes in a Multicenter Retrospective Study
Kennard, L., Rutkowski, K., Siew, L. Q. C., Nakonechna, A., Sargur, R. B., Egner, W., Shrimpton, A., Mirakian, R. M., & Wagner, A. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.03.018 · Cited by 21
Pérez‐Alzate, D., Blanca‐López, N., Doña, I., Agúndez, J. A. G., García‐Martín, E., Cornejo-García, J. A., Perkins, J. R., Blanca, M., & Cantó, G. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00215 · Cited by 20
Anaphylaxis to piperacillin–tazobactam despite a negative penicillin skin test
Rank, M. A., & Park, M. A. (2007) · Allergy · doi:10.1111/j.1398-9995.2007.01418.x · Cited by 19
Self-citationThe value of routine penicillin allergy skin testing in an outpatient population.
Warrington, R., Burton, R., & Tsai, E. L. (2003) · PubMed · Cited by 19
May, S., Motosue, M. S., & Park, M. A. (2016) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2016.11.011 · Cited by 19
Drug-Induced Liver Injury in the Setting of Analgesic Use
Darr, U., & Sussman, N. (2019) · Clinics in Liver Disease · doi:10.1016/j.cld.2019.09.008 · Cited by 18
Gagné, V., St-Onge, P., Beaulieu, P., Laverdière, C., Leclerc, J., Tran, T. H., Sallan, S. E., Neuberg, D. S., Silverman, L. B., Sinnett, D., et al. (2020) · Pharmacogenomics · doi:10.2217/pgs-2019-0195 · Cited by 18
Antibiotic allergy testing improves antibiotic appropriateness in patients with cancer
Trubiano, J. A., Grayson, M. L., Phillips, E. J., Stewardson, A. J., Thursky, K., & Slavin, M. A. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky307 · Cited by 17
Self-citation
Research works printed but not linked: 175
- Khan, 2012, Cutaneous drug reactions, J Allergy Clin Immunol, 130, 1225, 10.1016/j.jaci.2012.08.007 · doi:10.1016/j.jaci.2012.08.007
- Barbaud, 2020, Intradermal tests with drugs: an approach to standardization, Front Med, 7, 156, 10.3389/fmed.2020.00156 · doi:10.3389/fmed.2020.00156
- Blumenthal, 2019, Recorded penicillin allergy and risk of mortality: a population-based matched cohort study, J Gen Intern Med, 34, 1685, 10.1007/s11606-019-04991-y · DOI
- García Rodríguez, 2019, Provocation tests in nonimmediate hypersensitivity reactions to β-lactam antibiotics in children: are extended challenges needed?, J Allergy Clin Immunol Pract, 7, 265, 10.1016/j.jaip.2018.06.023 · doi:10.1016/j.jaip.2018.06.023
- Gallardo, 2020, Sensitization phenotypes in immediate reactions to piperacillin-tazobactam, J Allergy Clin Immunol Pract, 8, 3175, 10.1016/j.jaip.2020.04.008 · doi:10.1016/j.jaip.2020.04.008
- Doña, 2020, Clinical characterization and diagnostic approaches for patients reporting hypersensitivity reactions to quinolones, J Allergy Clin Immunol Pract, 8, 2707, 10.1016/j.jaip.2020.04.051 · doi:10.1016/j.jaip.2020.04.051
- Cavkaytar, 2016, Testing for clarithromycin hypersensitivity: a diagnostic challenge in childhood, J Allergy Clin Immunol Pract, 4, 10.1016/j.jaip.2015.09.015 · doi:10.1016/j.jaip.2015.09.015
- Sala-Cunill, 2021, One-dilution rapid desensitization protocol to chemotherapeutic and biological agents: a five-year experience, J Allergy Clin Immunol Pract, 9, 4045, 10.1016/j.jaip.2021.06.024 · doi:10.1016/j.jaip.2021.06.024
- Weiss, 1992, Hypersensitivity reactions, Semin Oncol, 19, 458
- Trudeau, 1996, Docetaxel in patients with metastatic breast cancer: a phase II study of the National Cancer Institute of Canada-Clinical Trials Group, J Clin Oncol, 14, 422, 10.1200/JCO.1996.14.2.422 · doi:10.1200/jco.1996.14.2.422
- Sánchez-López, 2015, Successful oral desensitization in a patient with hypersensitivity reaction to crizotinib, J Investig Allergol Clin Immunol, 25, 307
- Madrigal-Burgaleta, 2019, A large single-hospital experience using drug provocation testing and rapid drug desensitization in hypersensitivity to antineoplastic and biological agents, J Allergy Clin Immunol Pract, 7, 618, 10.1016/j.jaip.2018.07.031 · doi:10.1016/j.jaip.2018.07.031
- Lehloenya, 2011, Outcomes of reintroducing anti-tuberculosis drugs following cutaneous adverse drug reactions, Int J Tuberc Lung Dis, 15, 1649, 10.5588/ijtld.10.0698 · doi:10.5588/ijtld.10.0698
- Karmacharya, 2015, Rituximab-induced serum sickness: a systematic review, Semin Arthritis Rheum, 45, 334, 10.1016/j.semarthrit.2015.06.014 · doi:10.1016/j.semarthrit.2015.06.014
- Foong, 2016, Lack of uniformity in the investigation and management of suspected beta-lactam allergy in children, Pediatr Allergy Immunol, 27, 527, 10.1111/pai.12557 · doi:10.1111/pai.12557
- Picard, 2014, A new humanized in vitro model of IgE-mediated rapid desensitization, Clin Transl Allergy, 4, O10, 10.1186/2045-7022-4-S3-O10 · doi:10.1186/2045-7022-4-s3-o10
- Chiriac, 2017, Optimal step doses for drug provocation tests to prove beta-lactam hypersensitivity, Allergy, 72, 552, 10.1111/all.13037 · doi:10.1111/all.13037
- Ozturk, 2013, Determining safe alternatives for multidrug hypersensitive patients with the alternative triple antibiotic-analgesic test, Allergol Immunopathol (Madr), 41, 189, 10.1016/j.aller.2012.01.007 · doi:10.1016/j.aller.2012.01.007
- Guvenir, 2016, Proven non-beta-lactam antibiotic allergy in children, Int Arch Allergy Immunol, 169, 45, 10.1159/000443830 · doi:10.1159/000443830
- Zambonino, 2014, Diagnostic evaluation of hypersensitivity reactions to beta-lactam antibiotics in a large population of children, Pediatr Allergy Immunol, 25, 80, 10.1111/pai.12155 · doi:10.1111/pai.12155
- Vezir, 2014, The evaluation of drug provocation tests in pediatric allergy clinic: a single center experience, Allergy Asthma Proc, 35, 156, 10.2500/aap.2014.35.3744 · doi:10.2500/aap.2014.35.3744
- Indradat, 2016, Provocation proven drug allergy in Thai children with adverse drug reactions, Asian Pac J Allergy Immunol, 34, 59
- Sompornrattanaphan, 2020, Fatal anaphylaxis from a second amoxicillin/clavulanic acid provocation after a prior negative provocation, J Allergy Clin Immunol Pract, 8, 752, 10.1016/j.jaip.2019.07.022 · doi:10.1016/j.jaip.2019.07.022
- Putterman, 1990, "Treating through" hypersensitivity to co-trimoxazole in AIDS patients, Lancet, 336, 52, 10.1016/0140-6736(90)91563-P · doi:10.1016/0140-6736(90)91563-p
- Trautmann, 2017, "Treating through" decision and follow-up in antibiotic therapy-associated exanthemas, J Allergy Clin Immunol Pract, 5, 1650, 10.1016/j.jaip.2017.03.032 · doi:10.1016/j.jaip.2017.03.032
- Trubiano, 2021, Treating through drug-associated exanthems in drug allergy management: current evidence and clinical aspects, J Allergy Clin Immunol Pract, 9, 2984, 10.1016/j.jaip.2021.04.008 · DOI
- Lehloenya, 2015, Lack of cross-toxicity between isoniazid and ethionamide in severe cutaneous adverse drug reactions: a series of 25 consecutive confirmed cases, J Antimicrob Chemother, 70, 2648, 10.1093/jac/dkv158 · doi:10.1093/jac/dkv158
- Garcia-Neuer, 2018, Drug-induced paradoxical vocal fold motion, J Allergy Clin Immunol Pract, 6, 90, 10.1016/j.jaip.2017.08.020 · doi:10.1016/j.jaip.2017.08.020
- Raley, 2020, Drug-associated inducible laryngeal obstruction complicating penicillin allergy testing, Ann Allergy Asthma Immunol, 125, 599, 10.1016/j.anai.2020.06.031 · doi:10.1016/j.anai.2020.06.031
- Phillips, 2019, Controversies in drug allergy: testing for delayed reactions, J Allergy Clin Immunol, 143, 66, 10.1016/j.jaci.2018.10.030 · doi:10.1016/j.jaci.2018.10.030
- Barbaud, 2014, Skin testing and patch testing in non-IgE-mediated drug allergy, Curr Allergy Asthma Rep, 14, 442, 10.1007/s11882-014-0442-8 · doi:10.1007/s11882-014-0442-8
- Alvarez-Arango, 2021, Vancomycin immediate skin responses in vancomycin-naïve subjects, Clin Exp Allergy, 51, 932, 10.1111/cea.13850 · doi:10.1111/cea.13850
- Klaewsongkram, 2019, Analysis of HLA-B allelic variation and IFN-gamma ELISpot responses in patients with severe cutaneous adverse reactions associated with drugs, J Allergy Clin Immunol Pract, 7, 219, 10.1016/j.jaip.2018.05.004 · DOI
- Suthumchai, 2018, The measurement of drug-induced interferon gamma-releasing cells and lymphocyte proliferation in severe cutaneous adverse reactions, J Eur Acad Dermatol Venereol, 32, 992, 10.1111/jdv.14890 · doi:10.1111/jdv.14890
- Trubiano, 2017, Drug-specific upregulation of CD137 on CD8+ T cells aids in the diagnosis of multiple antibiotic toxic epidermal necrolysis, J Allergy Clin Immunol Pract, 5, 823, 10.1016/j.jaip.2016.09.043 · doi:10.1016/j.jaip.2016.09.043
- Fernandez, 2015, Genome-wide analysis links NFATC2 with asparaginase hypersensitivity, Blood, 126, 69, 10.1182/blood-2015-02-628800 · doi:10.1182/blood-2015-02-628800
- Khan, 2020, Pharmacogenomic biomarkers in allergy and immunology practice, J Allergy Clin Immunol, 146, 509, 10.1016/j.jaci.2020.05.050 · doi:10.1016/j.jaci.2020.05.050
- Macy, 2011, Reply. J Allergy Clin Immunol, 128, 686, 10.1016/j.jaci.2011.04.055 · doi:10.1016/j.jaci.2011.04.055
- Levine, 1967, Prediction of penicillin allergy by immunological tests, Ann N Y Acad Sci, 145, 298, 10.1111/j.1749-6632.1967.tb50227.x · doi:10.1111/j.1749-6632.1967.tb50227.x
- Ibia, 2000, Antibiotic rashes in children: a survey in a private practice setting, Arch Dermatol, 136, 849, 10.1001/archderm.136.7.849 · doi:10.1001/archderm.136.7.849
- Kerns, 1973, Ampicillin rash in children: relationship to penicillin allergy and infectious mononucleosis, Am J Dis Child, 125, 187, 10.1001/archpedi.1973.04160020023004 · doi:10.1001/archpedi.1973.04160020023004
- Patel, 1967, Skin rash with infectious mononucleosis and ampicillin, Pediatrics, 40, 910, 10.1542/peds.40.5.910 · doi:10.1542/peds.40.5.910
- Zhang, 2019, Drug-induced severe cutaneous adverse reactions: determine the cause and prevention, Ann Allergy Asthma Immunol, 123, 483, 10.1016/j.anai.2019.08.004 · doi:10.1016/j.anai.2019.08.004
- Marcos Bravo, 1995, Hypersensitivity to cefuroxime with good tolerance to other betalactams, Allergy, 50, 359, 10.1111/j.1398-9995.1995.tb01160.x · doi:10.1111/j.1398-9995.1995.tb01160.x
- Poston, 2004, Cefazolin tolerance does not predict ceftriaxone hypersensitivity: unique side chains precipitate anaphylaxis, Pharmacotherapy, 24, 668, 10.1592/phco.24.6.668.34753 · doi:10.1592/phco.24.6.668.34753
- Testi, 2010, Nonirritating concentration for skin testing with cephalosporins, J Investig Allergol Clin Immunol, 20, 171
- Koo, 2022, Retrospective stratification of cephalosporin allergy label risk using validated penicillin allergy frameworks, J Allergy Clin Immunol Pract, 10, 2472, 10.1016/j.jaip.2022.05.032 · doi:10.1016/j.jaip.2022.05.032
- Pedersen-Bjergaard, 1967, Cephalothin in the treatment of penicillin sensitive patients, Acta Allergol, 22, 299, 10.1111/j.1398-9995.1967.tb03226.x · doi:10.1111/j.1398-9995.1967.tb03226.x
- Shepherd, 1993, Administration of cephalosporin antibiotics to patients with a history of penicillin allergy, J Allergy Clin Immunol Pract, 91, 262
- Chiron, 2020, Allergy to third- and second-generation cephalosporins in confirmed penicillin-allergic patients, J Allergy Clin Immunol Pract, 8, 2409, 10.1016/j.jaip.2020.03.021 · doi:10.1016/j.jaip.2020.03.021
- Li, 2019, Cross-reactivity to penicillins in cephalosporin anaphylaxis, Br J Anaesth, 123, e532, 10.1016/j.bja.2019.09.011 · doi:10.1016/j.bja.2019.09.011
- Sodhi, 2004, Is it safe to use carbapenems in patients with a history of allergy to penicillin?, J Antimicrob Chemother, 54, 1155, 10.1093/jac/dkh454 · doi:10.1093/jac/dkh454
- Prescott, 2004, Incidence of carbapenem-associated allergic-type reactions among patients with versus patients without a reported penicillin allergy, Clin Infect Dis, 38, 1102, 10.1086/382880 · doi:10.1086/382880
- McConnell, 2000, Incidence of imipenem hypersensitivity reactions in febrile neutropenic bone marrow transplant patients with a history of penicillin allergy, Clin Infect Dis, 31, 1512, 10.1086/317507 · doi:10.1086/317507
- Sanchez-Borges, 2001, Tolerability to new COX-2 inhibitors in NSAID-sensitive patients with cutaneous reactions, Ann Allergy Asthma Immunol, 87, 201, 10.1016/S1081-1206(10)62226-0 · doi:10.1016/s1081-1206(10)62226-0
- Kula, 2014, A systematic review: can one prescribe carbapenems to patients with IgE-mediated allergy to penicillins or cephalosporins?, Clin Infect Dis, 59, 1113, 10.1093/cid/ciu587 · doi:10.1093/cid/ciu587
- Adkinson, 1990, Immunogenicity and cross-allergenicity of aztreonam, Am J Med, 88, S3
- Saxon, 1985, Investigation into the immunologic cross-reactivity of aztreonam with other beta-lactam antibiotics, Am J Med, 78, 19, 10.1016/0002-9343(85)90198-6 · doi:10.1016/0002-9343(85)90198-6
- Graninger, 1985, Aztreonam efficacy in difficult-to-treat infections and tolerance in patients with beta-lactam hypersensitivity, Chemioterapia, 4, 64
- Adkinson, 1984, Immunology of the monobactam aztreonam, Antimicrob Agents Chemother, 25, 93, 10.1128/AAC.25.1.93 · doi:10.1128/aac.25.1.93
- Adkinson, 1985, Cross-allergenicity and immunogenicity of aztreonam, Rev Infect Dis, 7, S613, 10.1093/clinids/7.Supplement_4.S613 · doi:10.1093/clinids/7.supplement_4.s613
- Vaisman, 2017, Clarifying a "penicillin" allergy: a teachable moment, JAMA Intern Med, 177, 269, 10.1001/jamainternmed.2016.8185 · doi:10.1001/jamainternmed.2016.8185
- Belchi-Hernandez, 1996, Management of adverse reactions to prophylactic trimethoprim-sulfamethoxazole in patients with human immunodeficiency virus infection, Ann Allergy Asthma Immunol, 76, 355, 10.1016/S1081-1206(10)60037-3 · doi:10.1016/s1081-1206(10)60037-3
- Ozkaya-Bayazit, 1999, Topical provocation in 27 cases of cotrimoxazole-induced fixed drug eruption, Contact Dermatitis, 41, 185, 10.1111/j.1600-0536.1999.tb06127.x · doi:10.1111/j.1600-0536.1999.tb06127.x
- Bonfanti, 2000, The effectiveness of desensitization versus rechallenge treatment in HIV-positive patients with previous hypersensitivity to TMP-SMX: a randomized multicentric study. CISAI Group, Biomed Pharmacother, 54, 45, 10.1016/S0753-3322(00)88640-0 · doi:10.1016/s0753-3322(00)88640-0
- Straatmann, 2002, A randomized, pilot trial comparing full versus escalating dose regimens for the desensitization of AIDS patients allergic to sulfonamides, Braz J Infect Dis, 6, 276, 10.1590/S1413-86702002000600002 · doi:10.1590/s1413-86702002000600002
- Leoung, 2001, Trimethoprim-sulfamethoxazole (TMP-SMZ) dose escalation versus direct rechallenge for Pneumocystis Carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with previous adverse reaction to TMP-SMZ, J Infect Dis, 184, 992, 10.1086/323353 · doi:10.1086/323353
- Gluckstein, 1995, Rapid oral desensitization to trimethoprim-sulfamethoxazole (TMP-SMZ): use in prophylaxis for Pneumocystis carinii pneumonia in patients with AIDS who were previously intolerant to TMP-SMZ, Clin Infect Dis, 20, 849, 10.1093/clinids/20.4.849 · doi:10.1093/clinids/20.4.849
- Hughes, 1986, Co-trimoxazole desensitization in bone marrow transplantation, Ann Intern Med, 105, 148, 10.7326/0003-4819-105-1-148 · doi:10.7326/0003-4819-105-1-148
- Soffritti, 2003, Successful desensitization to trimethoprim-sulfamethoxazole after allogeneic haematopoietic stem cell transplantation: preliminary observations, Med Pediatr Oncol, 40, 271, 10.1002/mpo.10196 · doi:10.1002/mpo.10196
- Krantz, 2021, Reply to “The safety and efficacy of direct oral challenge in trimethoprim-sulfamethoxazole antibiotic allergy”, J Allergy Clin Immunol Pract, 9, 3849, 10.1016/j.jaip.2021.07.027 · doi:10.1016/j.jaip.2021.07.027
- Ball, 2004, A new respiratory fluoroquinolone, oral gemifloxacin: a safety profile in context, Int J Antimicrob Agents, 23, 421, 10.1016/j.ijantimicag.2004.02.014 · doi:10.1016/j.ijantimicag.2004.02.014
- Manfredi, 2004, Detection of specific IgE to quinolones, J Allergy Clin Immunol, 113, 155, 10.1016/j.jaci.2003.09.035 · doi:10.1016/j.jaci.2003.09.035
- Venturini Diaz, 2017, In vivo diagnostic tests in adverse reactions to quinolones, J Investig Allergol Clin Immunol, 17, 393
- Anovadiya, 2011, Cross sensitivity between ciprofloxacin and levofloxacin for an immediate hypersensitivity reaction, J Pharmacol Pharmacother, 2, 187, 10.4103/0976-500X.83285 · doi:10.4103/0976-500x.83285
- Davila, 1993, Cross-reactivity between quinolones: report of three cases, Allergy, 48, 388, 10.1111/j.1398-9995.1993.tb02413.x · doi:10.1111/j.1398-9995.1993.tb02413.x
- Gonzalez-Mancebo, 2004, Immediate hypersensitivity to levofloxacin diagnosed through skin prick test, Ann Pharmacother, 38, 354, 10.1345/aph.1D159 · doi:10.1345/aph.1d159
- Lobera, 2010, Allergy to quinolones: low cross-reactivity to levofloxacin, J Investig Allergol Clin Immunol, 20, 607
- Sanchez-Morillas, 2010, Systemic anaphylaxis caused by moxifloxacin, Allergol Immunopathol (Madr), 38, 226, 10.1016/j.aller.2009.09.008 · doi:10.1016/j.aller.2009.09.008
- Demir, 2017, Usefulness of in vivo and in vitro diagnostic tests in the diagnosis of hypersensitivity reactions to quinolones and in the evaluation of cross-reactivity: a comprehensive study including the latest quinolone gemifloxacin, Allergy Asthma Immunol Res, 9, 347, 10.4168/aair.2017.9.4.347 · doi:10.4168/aair.2017.9.4.347
- Gea-Banacloche, 1996, Ciprofloxacin desensitization, J Allergy Clin Immunol, 97, 1426, 10.1016/S0091-6749(96)70218-X · doi:10.1016/s0091-6749(96)70218-x
- Lantner, 1995, Ciprofloxacin desensitization in a patient with cystic fibrosis, J Allergy Clin Immunol, 96, 1001, 10.1016/S0091-6749(95)70240-7 · doi:10.1016/s0091-6749(95)70240-7
- Treadway, 1996, Paediatric safety of azithromycin: worldwide experience, J Antimicrob Chemother, 37, 143, 10.1093/jac/37.suppl_C.143 · doi:10.1093/jac/37.suppl_c.143
- van der Linden, 1998, Skin reactions to antibacterial agents in general practice, J Clin Epidemiol, 51, 703, 10.1016/S0895-4356(98)00041-9 · doi:10.1016/s0895-4356(98)00041-9
- Benahmed, 2004, The accuracy of the diagnosis of suspected macrolide antibiotic hypersensitivity: results of a single-blinded trial, Allergy, 59, 1130, 10.1111/j.1398-9995.2004.00638.x · doi:10.1111/j.1398-9995.2004.00638.x
- Lammintausta, 2005, Oral challenge in patients with suspected cutaneous adverse drug reactions: findings in 784 patients during a 25-year-period, Acta Derm Venereol, 85, 491, 10.1080/00015550510042859 · doi:10.1080/00015550510042859
- Mori, 2010, Sensitivity and specificity of skin tests in the diagnosis of clarithromycin allergy, Ann Allergy Asthma Immunol, 104, 417, 10.1016/j.anai.2010.03.010 · doi:10.1016/j.anai.2010.03.010
- Laurie, 2000, Successful clarithromycin desensitization in a macrolide-sensitive patient (abstract), Ann Allergy Asthma Immunol, 84, 116
- Asero, 2005, Oral aspirin challenges in patients with a history of intolerance to single non-steroidal anti-inflammatory drugs, Clin Exp Allergy, 35, 713, 10.1111/j.1365-2222.2005.2228.x · doi:10.1111/j.1365-2222.2005.2228.x
- Asero, 2006, Use of ketoprofen oral challenges to detect cross-reactors among patients with a history of aspirin-induced urticaria, Ann Allergy Asthma Immunol, 97, 187, 10.1016/S1081-1206(10)60011-7 · doi:10.1016/s1081-1206(10)60011-7
- Kim, 2007, The prevalence of Samter's triad in patients undergoing functional endoscopic sinus surgery, Ear Nose Throat J, 86, 396, 10.1177/014556130708600715 · doi:10.1177/014556130708600715
- Dursun, 2008, Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis, Ann Allergy Asthma Immunol, 100, 420, 10.1016/S1081-1206(10)60465-6 · doi:10.1016/s1081-1206(10)60465-6
- Cook, 2017, Use of a composite symptom score during challenge in patients with suspected aspirin-exacerbated respiratory disease, Ann Allergy Asthma Immunol, 118, 597, 10.1016/j.anai.2017.02.016 · doi:10.1016/j.anai.2017.02.016
- Staso, 2021, Scoring tool for systemic symptoms during aspirin challenge detects mediator production in aspirin-exacerbated respiratory disease, Ann Allergy Asthma Immunol, 127, 131, 10.1016/j.anai.2021.03.025 · doi:10.1016/j.anai.2021.03.025
- White, 2013, The clinical dilemma of "silent desensitization" in aspirin-exacerbated respiratory disease, Allergy Asthma Proc, 34, 378, 10.2500/aap.2013.34.3670 · doi:10.2500/aap.2013.34.3670
- Lang, 2018, Omalizumab can inhibit respiratory reaction during aspirin desensitization, Ann Allergy Asthma Immunol, 121, 98, 10.1016/j.anai.2018.05.007 · doi:10.1016/j.anai.2018.05.007
- Huang, 2019, Sinus surgery improves lower respiratory tract reactivity during aspirin desensitization for AERD, J Allergy Clin Immunol Pract, 7, 1647, 10.1016/j.jaip.2019.02.037 · doi:10.1016/j.jaip.2019.02.037
- Chen, 2015, An hourly dose-escalation desensitization protocol for aspirin-exacerbated respiratory disease, J Allergy Clin Immunol Pract, 3, 926, 10.1016/j.jaip.2015.06.013 · doi:10.1016/j.jaip.2015.06.013
- Lee, 2010, Use of intranasal ketorolac and modified oral aspirin challenge for desensitization of aspirin-exacerbated respiratory disease, Ann Allergy Asthma Immunol, 105, 130, 10.1016/j.anai.2010.05.020 · doi:10.1016/j.anai.2010.05.020
- DeGregorio, 2019, A 1-day, 90-minute aspirin challenge and desensitization protocol in aspirin-exacerbated respiratory disease, J Allergy Clin Immunol Pract, 7, 1174, 10.1016/j.jaip.2018.10.032 · doi:10.1016/j.jaip.2018.10.032
- Pelletier, 2019, Comparable safety of 2 aspirin desensitization protocols for aspirin exacerbated respiratory disease, J Allergy Clin Immunol Pract, 7, 1319, 10.1016/j.jaip.2018.08.004 · doi:10.1016/j.jaip.2018.08.004
- Pleskow, 1982, Aspirin desensitization in aspirin-sensitive asthmatic patients: clinical manifestations and characterization of the refractory period, J Allergy Clin Immunol, 69, 11, 10.1016/0091-6749(82)90081-1 · DOI
- Wangberg, 2021, Perioperative management and perceived risks of sinus surgery in patients with aspirin-exacerbated respiratory disease, Int Forum Allergy Rhinol, 11, 1132, 10.1002/alr.22789 · doi:10.1002/alr.22789
- Do, 2019, Long-term assessment of aspirin desensitization shows successful bridging with non-aspirin nonsteroidal anti-inflammatory drugs for procedures, Allergy Asthma Proc, 40, 311, 10.2500/aap.2019.40.4239 · doi:10.2500/aap.2019.40.4239
- White, 2005, The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease, Ann Allergy Asthma Immunol, 95, 330, 10.1016/S1081-1206(10)61150-7 · doi:10.1016/s1081-1206(10)61150-7
- White, 2006, Effect of leukotriene modifier drugs on the safety of oral aspirin challenges, Ann Allergy Asthma Immunol, 97, 688, 10.1016/S1081-1206(10)61101-5 · doi:10.1016/s1081-1206(10)61101-5
- Kowalski, 1986, Clinical efficacy of aspirin in "desensitised" aspirin-sensitive asthmatics, Eur J Respir Dis, 69, 219
- Cho, 2014, Long-term sinonasal outcomes of aspirin desensitization in aspirin exacerbated respiratory disease, Otolaryngol Head Neck Surg, 151, 575, 10.1177/0194599814545750 · doi:10.1177/0194599814545750
- Sánchez-Borges, 2015, Aspirin-exacerbated cutaneous disease (AECD) is a distinct subphenotype of chronic spontaneous urticaria, J Eur Acad Dermatol Venereol, 29, 698, 10.1111/jdv.12658 · doi:10.1111/jdv.12658
- Asero, 2002, Autoreactivity is highly prevalent in patients with multiple intolerances to NSAIDs, Ann Allergy Asthma Immunol, 88, 468, 10.1016/S1081-1206(10)62384-8 · doi:10.1016/s1081-1206(10)62384-8
- Asero, 2003, Intolerance to nonsteroidal anti-inflammatory drugs might precede by years the onset of chronic urticaria, J Allergy Clin Immunol, 111, 1095, 10.1067/mai.2003.1444 · doi:10.1067/mai.2003.1444
- Perrone, 2003, Tolerability of rofecoxib in patients with adverse reactions to nonsteroidal anti-inflammatory drugs: a study of 216 patients and literature review, Int Arch Allergy Immunol, 132, 82, 10.1159/000073268 · doi:10.1159/000073268
- Nettis, 2002, Tolerability of rofecoxib in patients with cutaneous adverse reactions to nonsteroidal anti-inflammatory drugs, Ann Allergy Asthma Immunol, 88, 331, 10.1016/S1081-1206(10)62017-0 · doi:10.1016/s1081-1206(10)62017-0
- Sánchez, 2020, Clinical control of CSU with antihistamines allows for tolerance of NSAID-exacerbated cutaneous disease, J Allergy Clin Immunol Pract, 8, 3577, 10.1016/j.jaip.2020.06.057 · doi:10.1016/j.jaip.2020.06.057
- Walters, 2016, Tolerance to nonsteroidal anti-inflammatory drugs and alcohol after omalizumab treatment in a patient with chronic urticaria, Ann Allergy Asthma Immunol, 117, 559, 10.1016/j.anai.2016.08.020 · doi:10.1016/j.anai.2016.08.020
- Asero, 2018, Restoration of aspirin tolerance following omalizumab treatment in a patient with chronic spontaneous urticaria, Eur Ann Allergy Clin Immunol, 50, 226, 10.23822/EurAnnACI.1764-1489.36 · doi:10.23822/eurannaci.1764-1489.36
- Doña, 2017, Natural evolution in patients with nonsteroidal anti-inflammatory drug-induced urticaria/angioedema, Allergy, 72, 1346, 10.1111/all.13147 · doi:10.1111/all.13147
- Doña, 2014, NSAID-induced urticaria/angioedema does not evolve into chronic urticaria: a 12-year follow-up study, Allergy, 69, 438, 10.1111/all.12335 · doi:10.1111/all.12335
- Goksel, 2010, Safety of meloxicam in patients with aspirin/non-steroidal anti-inflammatory drug-induced urticaria and angioedema, J Dermatol, 37, 973, 10.1111/j.1346-8138.2010.00948.x · doi:10.1111/j.1346-8138.2010.00948.x
- Rossini, 2008, Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation, Am J Cardiol, 101, 786, 10.1016/j.amjcard.2007.10.045 · doi:10.1016/j.amjcard.2007.10.045
- Silberman, 2005, Rapid desensitization procedure for patients with aspirin hypersensitivity undergoing coronary stenting, Am J Cardiol, 95, 509, 10.1016/j.amjcard.2004.10.022 · doi:10.1016/j.amjcard.2004.10.022
- Moore, 1980, Nonsteroidal anti-inflammatory intolerance. an anaphylactic reaction to tolmetin, Arch Intern Med, 140, 1105, 10.1001/archinte.1980.00330190117037 · doi:10.1001/archinte.1980.00330190117037
- Alkhawajah, 1993, Fatal anaphylactic reaction to diclofenac, Forensic Sci Int, 60, 107, 10.1016/0379-0738(93)90098-U · doi:10.1016/0379-0738(93)90098-u
- Himly, 2003, IgE-mediated immediate-type hypersensitivity to the pyrazolone drug propyphenazone, J Allergy Clin Immunol, 111, 882, 10.1067/mai.2003.163 · doi:10.1067/mai.2003.163
- Couto, 2012, IgE-mediated metamizol allergy and the usefulness of the cellular allergen stimulation test, Eur Ann Allergy Clin Immunol, 44, 113
- Fontaine, 2005, Anaphylactic shock caused by a selective allergy to celecoxib, with no allergy to rofecoxib or sulfamethoxazole, J Allergy Clin Immunol, 115, 633, 10.1016/j.jaci.2004.10.045 · doi:10.1016/j.jaci.2004.10.045
- Cortellini, 2017, Clinical approach on challenge and desensitization procedures with aspirin in patients with ischemic heart disease and nonsteroidal anti-inflammatory drug hypersensitivity, Allergy, 72, 498, 10.1111/all.13068 · doi:10.1111/all.13068
- Gendernalik, 2009, Fixed drug eruptions: a case report and review of the literature, Cutis, 84, 215
- Blanca-López, 2018, Acetyl salicylic acid challenge in children with hypersensitivity reactions to nonsteroidal anti-inflammatory drugs differentiates between cross-intolerant and selective responders, J Allergy Clin Immunol Pract, 6, 1226, 10.1016/j.jaip.2017.08.029 · doi:10.1016/j.jaip.2017.08.029
- Mori, 2020, A multicenter retrospective study on hypersensitivity reactions to nonsteroidal anti-inflammatory drugs (NSAIDs) in children: a report from the European Network on Drug Allergy (ENDA) Group, J Allergy Clin Immunol Pract, 8, 1022, 10.1016/j.jaip.2019.10.049 · doi:10.1016/j.jaip.2019.10.049
- Cousin, 2016, Phenotypical characterization of children with hypersensitivity reactions to NSAIDs, Pediatr Allergy Immunol, 27, 743, 10.1111/pai.12596 · doi:10.1111/pai.12596
- Camara, 2005, Clopidogrel (Plavix) desensitization: a case series, Catheter Cardiovasc Interv, 65, 525
- Camara, 2007, Clopidogrel (Plavix) desensitization protocol, Catheter Cardiovasc Interv, 69, 154
- Makrilia, 2010, Hypersensitivity reactions associated with platinum antineoplastic agents: a systematic review, Met Based Drugs, 2010, 10.1155/2010/207084 · doi:10.1155/2010/207084
- Shibata, 2009, Oxaliplatin-induced allergic reaction in patients with colorectal cancer in Japan, Int J Clin Oncol, 14, 397, 10.1007/s10147-009-0883-6 · doi:10.1007/s10147-009-0883-6
- Pellegrino, 2017, Nab-paclitaxel after docetaxel hypersensitivity reaction: case report and literature review, Acta Biomed, 88, 329
- Tsao, 2022, Hypersensitivity reactions to platinum agents and taxanes, Clin Rev Allergy Immunol, 62, 432, 10.1007/s12016-021-08877-y · DOI
- Pasteur, 2019, Low cross-reactivity between cisplatin and other platinum salts, J Allergy Clin Immunol Pract, 7, 1894, 10.1016/j.jaip.2019.01.057 · doi:10.1016/j.jaip.2019.01.057
- Sánchez-Muñoz, 2011, Cross-sensitivity between taxanes in patients with breast cancer, Clin Transl Oncol, 13, 904, 10.1007/s12094-011-0753-3 · doi:10.1007/s12094-011-0753-3
- Dizon, 2006, Cross-sensitivity between paclitaxel and docetaxel in a women's cancers program, Gynecol Oncol, 100, 149, 10.1016/j.ygyno.2005.08.004 · doi:10.1016/j.ygyno.2005.08.004
- Koren, 2002, Hypersensitivity reaction to cisplatin during chemoradiation therapy for gynecologic malignancy, Am J Clin Oncol, 25, 625, 10.1097/00000421-200212000-00020 · doi:10.1097/00000421-200212000-00020
- Polyzos, 2009, Clinical features of hypersensitivity reactions to oxaliplatin: a 10-year experience, Oncology, 76, 36, 10.1159/000178163 · doi:10.1159/000178163
- Syrigou, 2010, Administration of cisplatin in three patients with carboplatin hypersensitivity: is skin testing useful?, Anticancer Drugs, 21, 333, 10.1097/CAD.0b013e32833418c0 · doi:10.1097/cad.0b013e32833418c0
- Leguy-Seguin, 2007, Diagnostic and predictive value of skin testing in platinum salt hypersensitivity, J Allergy Clin Immunol, 119, 726, 10.1016/j.jaci.2006.11.640 · doi:10.1016/j.jaci.2006.11.640
- Koshiba, 2009, Incidence of Carboplatin-related hypersensitivity reactions in Japanese patients with gynecologic malignancies, Int J Gynecol Cancer, 19, 460, 10.1111/IGC.0b013e3181a1bf2e · doi:10.1111/igc.0b013e3181a1bf2e
- Goldberg, 1996, A modified, prolonged desensitization protocol in carboplatin allergy, J Allergy Clin Immunol, 98, 841, 10.1016/S0091-6749(96)70134-3 · doi:10.1016/s0091-6749(96)70134-3
- Gomez, 2009, Carboplatin hypersensitivity: does introduction of skin test and desensitization reliably predict and avoid the problem? A prospective single-center study, Int J Gynecol Cancer, 19, 1284, 10.1111/IGC.0b013e3181a418ff · doi:10.1111/igc.0b013e3181a418ff
- Levin, 2020, Platin risk stratification algorithm with modified intradermal skin test protocol, J Allergy Clin Immunol Pract, 8, 1139, 10.1016/j.jaip.2019.08.055 · doi:10.1016/j.jaip.2019.08.055
- Chung, 2018, A new non-dilution rapid desensitization protocol successfully applied to all-grade platinum hypersensitivity, Cancer Chemother Pharmacol, 82, 777, 10.1007/s00280-018-3662-0 · doi:10.1007/s00280-018-3662-0
- Madrigal-Burgaleta, 2013, Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment, Allergy, 68, 853, 10.1111/all.12105 · doi:10.1111/all.12105
- Alvarez-Cuesta, 2015, Delving into cornerstones of hypersensitivity to antineoplastic and biological agents: value of diagnostic tools prior to desensitization, Allergy, 70, 784, 10.1111/all.12620 · doi:10.1111/all.12620
- Otani, 2018, Utility of risk stratification for paclitaxel hypersensitivity reactions, J Allergy Clin Immunol Pract, 6, 1266, 10.1016/j.jaip.2017.08.025 · doi:10.1016/j.jaip.2017.08.025
- De Lira-Quezada, 2018, Early and delayed hypersensitivity reactions to paclitaxel: desensitization as a challenge, Ann Allergy Asthma Immunol, 121, S72, 10.1016/j.anai.2018.09.234 · doi:10.1016/j.anai.2018.09.234
- Horvat, 2016, The use of Erwinia asparaginase for adult patients with acute lymphoblastic leukemia after pegaspargase intolerance, Leuk Res, 50, 17, 10.1016/j.leukres.2016.08.014 · doi:10.1016/j.leukres.2016.08.014
- August, 2020, Desensitization to pegaspargase in children with acute lymphoblastic leukemia and lymphoblastic lymphoma, Pediatr Blood Cancer, 67, 10.1002/pbc.28021 · doi:10.1002/pbc.28021
- Sato, 2020, Osimertinib-associated toxic epidermal necrolysis in a lung cancer patient harboring an EGFR mutation—a case report and a review of the literature, Medicina (Kaunas), 56, 403, 10.3390/medicina56080403 · doi:10.3390/medicina56080403
- Pasadyn, 2020, Cutaneous adverse effects of biologic medications, Cleve Clin J Med, 87, 288, 10.3949/ccjm.87a.19119 · doi:10.3949/ccjm.87a.19119
- Iimura, 2018, NSAIDs may prevent EGFR-TKI-related skin rash in non-small cell lung cancer patients, Int J Clin Pharmacol Ther, 56, 551, 10.5414/CP203323 · doi:10.5414/cp203323
- Makino, 2013, Treatment strategy for reducing the risk of rituximab-induced cytokine release syndrome in patients with intravascular large B-cell lymphoma: a case report and review of the literature, J Med Case Rep, 7, 280, 10.1186/1752-1947-7-280 · doi:10.1186/1752-1947-7-280
- Gold, 2017, Premedication use in preventing acute infliximab infusion reactions in patients with inflammatory bowel disease: a single center cohort study, Inflamm Bowel Dis, 23, 1882, 10.1097/MIB.0000000000001189 · doi:10.1097/mib.0000000000001189
- Rocchi, 2014, Hypersensitivity reactions to tocilizumab: role of skin tests in diagnosis, Rheumatology (Oxford), 53, 1527, 10.1093/rheumatology/keu181 · doi:10.1093/rheumatology/keu181
- Cansever, 2018, Successful slow desensitization to tocilizumab in a 15-year-old patient, J Investig Allergol Clin Immunol, 28, 436, 10.18176/jiaci.0314 · doi:10.18176/jiaci.0314
- Sakaue, 2014, Tocilizumab-induced leucocytoclastic vasculitis in a patient with rheumatoid arthritis, Rheumatology (Oxford), 53, 1529, 10.1093/rheumatology/keu008 · doi:10.1093/rheumatology/keu008
- Cortellini, 2018, Effective desensitization to tocilizumab in delayed hypersensitivity reaction, Pharmacology, 102, 114, 10.1159/000490419 · doi:10.1159/000490419
- Weiss, 2020, A case of serum sickness-like reaction in an adult treated with omalizumab, Mil Med, 185, e912, 10.1093/milmed/usz357 · doi:10.1093/milmed/usz357
- Jeimy, 2019, Dermatomyositis associated with omalizumab therapy for severe asthma: a case report, Allergy Asthma Clin Immunol, 15, 4, 10.1186/s13223-019-0319-4 · doi:10.1186/s13223-019-0319-4
- Brockow, 2021, "Idiopathic" anaphylaxis caused by carboxymethylcellulose in ice cream, J Allergy Clin Immunol Pract, 9, 555, 10.1016/j.jaip.2020.10.051 · doi:10.1016/j.jaip.2020.10.051
- Klein, 1998, Anaphylaxis from the carboxymethylcellulose component of barium sulfate suspension, N Engl J Med, 338, 623, 10.1056/NEJM199802263380915 · doi:10.1056/nejm199802263380915
- Ohnishi, 2019, Anaphylaxis to carboxymethylcellulose: add food additives to the list of elicitors, Pediatrics, 143, 10.1542/peds.2018-1180 · doi:10.1542/peds.2018-1180
- Bircher, 2004, Oral tolerance of carboxymethylcellulose in patients with anaphylaxis to parenteral carboxymethylcellulose, Ann Allergy Asthma Immunol, 92, 580, 10.1016/S1081-1206(10)61769-3 · doi:10.1016/s1081-1206(10)61769-3
- Garcia-Ortega, 2003, Carboxymethylcellulose allergy as a cause of suspected corticosteroid anaphylaxis, Ann Allergy Asthma Immunol, 91, 421, 10.1016/S1081-1206(10)61698-5 · doi:10.1016/s1081-1206(10)61698-5
- Rutkowski, 2020, Immediate hypersensitivity reactions to steroids and steroid containing medications, Curr Opin Allergy Clin Immunol, 20, 362, 10.1097/ACI.0000000000000655 · doi:10.1097/aci.0000000000000655
- Bonanni, 2021, Anaphylaxis after injecting a hemostatic agent containing gelatin into vertebral bone under pressure-a warning, Spine Deform, 9, 1191, 10.1007/s43390-020-00273-4 · doi:10.1007/s43390-020-00273-4
- Aminsharifi, 2019, Major complications and adverse events related to the injection of the SpaceOAR hydrogel system before radiotherapy for prostate cancer: review of the manufacturer and user facility device experience database, J Endourol, 33, 868, 10.1089/end.2019.0431 · doi:10.1089/end.2019.0431
- Scheman, 2018, Contact allergy to propylene glycol and cross-reactions, Dermatitis, 29, 350, 10.1097/DER.0000000000000416 · doi:10.1097/der.0000000000000416
Cited by
Hardin, H., Shao, W., & Bernstein, J. A. (2023) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2023.08.022 · Cited by 10
Self-citation
Metadata
- Authors
- Khan, D. A., Banerji, A., Blumenthal, K. G., Phillips, E. J., Solensky, R., White, A. A., Bernstein, J. A., Chu, D. K., Ellis, A. K., Golden, D. B. K., Greenhawt, M. J., Horner, C. C., Ledford, D., Lieberman, J. A., Oppenheimer, J., Rank, M. A., Shaker, M. S., Stukus, D. R., Wallace, D., Wang, J., Khan, D. A., Golden, D. B. K., Shaker, M., Stukus, D. R., Khan, D. A., Banerji, A., Blumenthal, K. G., Phillips, E. J., Solensky, R., White, A. A., Bernstein, J. A., Chu, D. K., Ellis, A. K., Golden, D. B. K., Greenhawt, M. J., Horner, C. C., Ledford, D., Lieberman, J. A., Oppenheimer, J., Rank, M. A., Shaker, M. S., Stukus, D. R., Wallace, D., & Wang, J.
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2022-12
- Volume
- 150
- Issue
- 6
- Pages
- 1333-1393
- ISSN
- 0091-6749 (ISSN-L)
- OpenAlex
- W4296178925
- Cited by
- 563
- References
- 418
- FWCI
- 48.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (am, 369 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.